other material
confidence high
sentiment neutral
materiality 0.70
Aethlon Medical stockholders approve charter amendments and 2020 Equity Incentive Plan increase
AETHLON MEDICAL INC
- Stockholders approved increasing authorized common stock from 20,000,000 to 200,000,000 shares and authorizing 20,000,000 preferred shares, $0.001 par value.
- Stockholders approved adding 100,000 shares to the 2020 Equity Incentive Plan; the proposal received 204,289 votes for and 8,407 against.
- Stockholders approved issuing up to 1,126,602 common shares upon exercise of July 2026 Common Warrants and Placement Agent Warrants under Nasdaq Rule 5635(d).
- Annual Meeting held October 1, 2026; 399,752 of 711,136 shares (56.21%) represented by proxy or virtually, establishing a quorum.
- Five directors elected: Edward G. Broenniman, James B. Frakes, Nicolas Gikakis, Angela Rossetti, and Chetan S. Shah, MD.